NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional, and Neurocognitive Outcomes-Reference-Cited by-同舟云学术

NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional, and Neurocognitive Outcomes

Published:2012-02 Issue:2 Volume:18 Page:162-171
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Parsons Susan K.,Phipps Sean,Sung Lillian,Baker K. Scott,Pulsipher Michael A.,Ness Kirsten K.

Funder

National Institute of Health

ACS

American Lebanese Syrian Associated Charities

St. Baldrick’s Foundation and the Lance Armstrong Foundation

Genzyme, Otsuka America Pharmaceutical, Inc.

Sigma-Tau Pharmaceuticals, Inc

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference75 articles.

1. World Health Organization Constitution,1948

2. A critical appraisal of the quality of quality-of-life measurements;Gill;JAMA,1994

3. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes;Wilson;JAMA,1995

4. Conceptualization and Measurement of Health for Children in the Health Insurance Study;Eisen,1990

5. Maternal perspectives on children’s health-related quality of life during the first year after pediatric hematopoietic stem cell transplant;Parsons;J Pediatr Psychol,2006

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Living with the threat of losing a child: Parents' experiences of the transplantation process with a severely ill child who received stem cells from a sibling;Journal of Pediatric Nursing;2024-07

2. Severely reduced physical performance is already present at the time of admission for stem cell transplantation;BMJ Open Sport & Exercise Medicine;2024-06

3. Intensive Care Risk and Long-Term Outcomes in Pediatric Allogeneic Hematopoietic Cell Transplant Recipients;Blood Advances;2023-12-21

4. Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients;2023-08-05

5. Late Effects in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation for Nonmalignant Diseases: Proxy- and Patient-Reported Outcomes;Transplantation and Cellular Therapy;2023-03